COMMUNIQUÉS West-GlobeNewswire

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24/04/2026
Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment gap WHO prequalification key milestone for donor-funded and public sector [...]
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24/04/2026
Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment gap WHO prequalification key milestone for donor-funded and public sector [...]
Les 250 meilleurs spécialistes du cancer se réunissent en Belgique pour repousser les frontières de la protonthérapie
24/04/2026
IBA réunit les experts les plus renommés en protonthérapie venant des institutions de soins oncologiques les plus prestigieuses. Louvain-la-Neuve, Belgique, le 24 avril 2026 – IBA (Ion Beam Applications S.A., EURONEXT [...]
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
24/04/2026
“Totality of evidence” approach to evaluate SCENESSE® EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo study EMA emphasised its “totality of evidence” approach central [...]
The top 250 cancer specialists converge in Belgium to push the frontiers of proton therapy
24/04/2026
IBA gathers the most knowledgeable proton therapy experts coming from the most prestigious cancer care institutions. Louvain-La-Neuve, Belgium, April 24, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world [...]
Vistin Pharma ASA: First quarter 2026 financial results
24/04/2026
Vistin Pharma ASA: First quarter 2026 financial results Oslo, Norway, 24 th of April 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2026. First quarter revenue of MNOK 112 [...]
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
24/04/2026
Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing loss White Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and [...]
Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
23/04/2026
ISELIN, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics” or the “Company”), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab [...]
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
23/04/2026
LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 28, 2026 at 8:30 a.m. Eastern [...]
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
24/04/2026
-- Cash and Cash Investments at December 31, 2025 of €116.5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected to Extend Cash Runway into First Half of 2029 -- -- Positive [...]
Trevi Therapeutics to Participate in Upcoming May Events
23/04/2026
NEW HAVEN, Conn., April 23, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
23/04/2026
WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
AVITA Medical to Announce First Quarter 2026 Financial Results
23/04/2026
VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial [...]
Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
23/04/2026
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the first quarter 2026 ended March 31, 2026, before market open on [...]
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
24/04/2026
WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial results. Full Year 2025 [...]
Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
23/04/2026
Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a [...]
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
23/04/2026
SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the [...]
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
23/04/2026
Management to be Joined by Two Clinical Leaders in the Breast Cancer Field Expected to Complete Enrollment in Ongoing ELAINE-3 Phase 3 Registrational Study of Lasofoxifene in Metastatic Breast Cancer in 4Q26 with Data [...]
Denta Biome Under Investigation: Adem Naturals Chewable Dental Tablets for Oral Health Care Support
23/04/2026
A 2026 informational overview of Denta Biome chewable dental tablets, oral postbiotic science, FabM enzyme research context, gum health and bad breath ingredient analysis, pricing structure, and consumer verification [...]

Pages